Gileads TwiceYearly Lenacapavir Demonstrated 100 Efficacy and Superiority to Daily Truvada for HIV Prevention Gilead Sciences

– First Phase 3 HIV Prevention Trial Ever to Show Zero Infections – – Independent Data Monitoring Committee Recommended That Gilead Stop the Blinded Phase of the PURPOSE 1 Trial at Interim Analysis … [+17497 chars]Read More